Home/Filings/4/0001104659-23-022788
4//SEC Filing

Richardson Linda M 4

Accession 0001104659-23-022788

CIK 0001270073other

Filed

Feb 15, 7:00 PM ET

Accepted

Feb 16, 4:01 PM ET

Size

4.9 KB

Accession

0001104659-23-022788

Insider Transaction Report

Form 4
Period: 2023-02-14
Richardson Linda M
EVP & Chief Commercial Officer
Transactions
  • Tax Payment

    Common Stock

    2023-02-14$21.21/sh386$8,18743,291 total
Footnotes (1)
  • [F1]Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock unit award previously granted to the reporting person.

Issuer

INTERCEPT PHARMACEUTICALS, INC.

CIK 0001270073

Entity typeother

Related Parties

1
  • filerCIK 0001595064

Filing Metadata

Form type
4
Filed
Feb 15, 7:00 PM ET
Accepted
Feb 16, 4:01 PM ET
Size
4.9 KB